Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats

Veterinary Microbiology

Volumn 169, Issue 3-4, 2014, Pages 154-162

  Bálint, Ádám ^a   Farsang, Attila ^a   Szeredi, Levente ^a   Zádori, Zoltán ^b   Belák, Sándor ^c  

^a CENTRAL VETERINARY INSTITUTE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Feline coronavirus; Feline infectious peritonitis; Protection; Vaccine

Indexed keywords

FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; PROTECTION; VACCINE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CAT DISEASES; CATS; CORONAVIRUS INFECTIONS; CORONAVIRUS, FELINE; FECES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84894232858     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.10.015     Document Type: Article

References (53)

1. Addie D., Jarrett O. A study of naturally occurring feline coronavirus infections in kittens. Vet. Rec. 1992, 130:133-137.
2. Bálint Á., Farsang A., Zádori Z., Hornyák Á., Dencso L., Almazán F., Enjuanes L., Belák S. Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies on the role of ORF3abc in viral cell tropism. J. Virol. 2012, 86:6258-6267.
3. Bálint Á., Farsang A., Zádori Z., Belák S. Comparative in vivo analysis of recombinant type II feline coronaviruses with truncated and completed ORF3 region. Plos One 2013, 10.1371/journal.pone.0088758.
4. Barlough J.E., Stoddart C.A., Sorresso G.P., Jacobson R.H., Scott F.V. Experimental inoculation of cats with canine coronavirus and subsequent challenge with feline infectious peritonitis virus. Lab. Anim. Sci. 1984, 34:592-597.
5. Barlough J.E., Johnson-Lussenburg C.M., Stoddart C.A., Jacobson R.H., Scott F.W. Experimental inoculation of cats with human coronavirus 229E and subsequent challenge with feline infectious peritonitis virus. Can. J. Comp. Med. 1985, 49:303-307.
6. Chang H.W., de Groot R.J., Egberink H.F., Rottier P.J. Feline infectious peritonitis; insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J. Gen. Virol. 2010, 91:415-420.
7. Chen I.C., Wang S.M., Yu C.K., Liu C.C. Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice. Med. Microbiol. Immunol. 2013, [Epub ahead of print].
8. Corapi W.V., Olsen C.W., Scott F.W. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 1992, 66:6695-6705.
9. de Groot-Mijnes J.D., van Dun J.M., van der Most R.G., de Groot R.J. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J.Virol. 2005, 79:1036-1044.
10. Fehr D., Holznagel E., Bolla S., Hauser B., Herrewegh A.A., Horzinek M.C., Lutz H. Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions. Vaccine 1997, 15:1101-1109.
11. Gerber J.D., Ingersoll J.D., Gast A.M., Christianson K.K., Selzer N.L., Landon R.M., Pfeiffer N.E., Sharpee R.L., Beckenhauer W.H. Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine. Vaccine 1990, 8:536-542.
12. Gerber J.D. Overview of the development of a modified live temperature-sensitive FIP virus vaccine. Feline Pract. 1995, 23:62-66.
13. Haijema B.J., Volders H., Rottier P.J. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol. 2004, 78:3863-3871.
14. Haijema B.J., Rottier P.J.M., de Groot R.J. Feline coronaviruses: a tale of two-faced types. Coronaviruses. 2007, Caister Academic Press, UK: Norfolk. Caister Academic Press.
15. Herrewegh A.A., Mahler M., Hedrich H.J., Haagmans B.L., Egberink H.F., Horzinek M.C., Rottier P.J., de Groot R.J. Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 1997, 234:349-363.
16. Herrewegh A.A., Smeenk I., Horzinek M.C., Rottier P.J., de Groot R.J. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J. Virol. 1998, 72:4508-4514.
17. Hohdatsu T., Okada S., Ishizuka Y., Yamada H., Koyama H. The prevalence of types I and II feline coronavirus infections in cats. J. Vet. Med. Sci. 1992, 54:557-562.
18. Hohdatsu T., Yamada M., Tominaga R., Makino K., Kida K., Koyama H. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus. J. Vet. Med. Sci. 1998, 60:49-55.
19. Iankov I.D., Penheiter A.R., Griesmann G.E., Carlson S.K., Federspiel M.J., Galanis E. Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells. Virus Res. 2013, 172:15-23.
20. Ivec M., Botić T., Koren S., Jakobsen M., Weingartl H., Cencic A. Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Res. 2007, 75:266-274.
21. Klaasen H.L., Van der Heijden P.J., Stok W., Poelma F.G., Koopman J.P., Van den Brink M.E., Bakker M.H., Eling W.M., Beynen A.C. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect. Immun. 1993, 61:303-306.
22. Kummrow M., Meli M.L., Haessig M., Goenczi E., Poland A., Pedersen N.C., Hofmann-Lehmann R., Lutz H. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin. Diagn. Lab. Immunol. 2005, 12:1209-1215.
23. Kuss S.K., Best G.T., Etheredge C.A., Pruijssers A.J., Frierson J.M., Hooper L.V., Dermody T.S., Pfeiffer J.K. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011, 334:249-252.
24. Lamousé-Smith E.S., Tzeng A., Starnbach M.N. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One 2011, 6:e27662.
25. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
26. McArdle F., Tennant B., Bennett M., Kelly D.F., Gaskell C.J., Gaskell R.M. Independent evaluation of a modified live FIPV vaccine under experimental conditions (University of Liverpool experience). Feline Pract. 1995, 23:67-71.
27. Norris J.M., Bosward K.L., White J.D., Baral R.M., Catt M.J., Malik R. Clinicopathological findings associated with feline infectious peritonitis in Sydney Australia: 42 cases (1990-002). Aust. Vet. J. 2005, 83:666-673.
28. Olsen C.W., Corapi W.V., Ngichabe C.K., Baines J.D., Scott F.W. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J. Virol. 1992, 66:956-965.
29. Paltrinieri S., Cammarata Parodi M., Cammarata G., Mambretti M. Type IV hypersensitivity in the pathogenesis of FIPV-induced lesions. Zentralblatt Vet. Med. B. 1989, 45:151-159.
30. Pedersen N.C., Boyle J.F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am. J. Vet. Res. 1980, 41:868-876.
31. Pedersen N.C., Boyle J.F., Floyd K., Fudge A., Barker J. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am. J. Vet. Res. 1981, 42:368-377.
32. Pedersen N.C., Black J.W. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am. J. Vet. Res. 1983, 44:229-234.
33. Pedersen N.C., Evermann J.F., McKeirnan A.J., Ott R.L. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am. J. Vet. Res. 1984, 45:2580-2585.
34. Pedersen N.C., Floyd K. Experimental studies with three new strains of feline infectious peritonitis virus: FIPV-UCD2 FIPV-UCD3, and FIPV-UCD4. Compend. Contin. Educ. Pract. Vet. 1985, 7:1001-1011.
35. Pedersen N.C. Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv. Exp. Med. Biol. 1987, 218:529-550.
36. Pedersen N.C. Animal virus infections that defy vaccination: equine infectious anemia, caprine arthritis-encephalitis, maedi-visna, and feline infectious peritonitis. Adv. Vet. Sci. Comp. Med. 1989, 3:413-428.
37. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J. Feline Med. Surg. 2009, 11:225-258.
38. Pedersen N.C., Liu H., Scarlett J., Leutenegger C.M., Golovko L., Kennedy H., Kamal F.M. Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats. Virus Res. 2012, 165:17-28.
39. Peiris J.S., Porterfield J.S. Antibody-mediated enhancement of flavivirus replication in macrophage-like cell lines. Nature 1979, 282:509-511.
40. Porterfield J.S. Antibody-dependent enhancement of viral infectivity. Adv. Virus Res. 1986, 31:335-355.
41. Scott F.W., Corapi W.V., Olsen C.W. Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline Pract. 1995, 23:74-76.
42. Shiba N., Maeda K., Kato H., Mochizuki M., Iwata H. Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet. Microbiol. 2007, 124:348-352.
43. Slifka M.K., Homann D., Tishon A., Pagarigan R., Oldstone M.B.A. Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J. Clin. Invest. 2003, 111:805-810.
44. Stoddart C.A., Barlough J.E., Baldwin C.A., Scott F.W. Attempted immunisation of cats against feline infectious peritonitis using canine coronavirus. Res. Vet. Sci. 1988, 45:383-388.
45. Takeda A., Tuazon C.U., Ennis F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988, 242:580-583.
46. Takano T., Kawakami C., Yamada S., Satoh R., Hohdatsu T. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. J. Vet. Med. Sci. 2008, 70:1315-1321.
47. Tamura M., Webster R.G., Ennis F.A. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 1991, 182:211-219.
48. Teixeira L., Ferreira A., Ashburner M. The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster. PLoS Biol. 2008, 6:1000002e.
49. Vennema H., de Groot R.J., Harbour D.A., Dalderup M., Gruffydd-Jones T., Horzinek M.C., Spaan W.J. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 1990, 64:1407-1409.
50. Vennema H., Poland A., Foley J., Pedersen N.C. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998, 243:150-157.
51. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 1981, 4:175-189.
52. Wilks J., Golovkina T. Influence of microbiota on viral infections. PLoS Pathog. 2012, 8:e1002681.
53. Woods R.D., Pedersen N.C. Cross-protection studies between feline infectious peritonitis virus and porcine transmissible gastroenteritis viruses. Vet. Microbiol. 1979, 4:11-16.